No Detail Found!

Comparison of Serum Prolidase Activity in Smokers and Non-Smokers

Author(s)
Tahire Betul Kor Department of Family Medicine, Aksaray Community Health Centre, Family Medicine,Aksaray,Turkiye
Basri Furkan Dagcioglu Department of Family Medicine, Ankara Bilkent City Hospital, Faculty of Medicine, Ankara Yildirim Beyazit University,Ankara,Turkiye
Aygul Tikit Department of Medical Biochemistry, Ankara Bilkent City Hospital,Ankara,Turkiye
Salim Neselioglu Department of Medical Biochemistry, Ankara Bilkent City Hospital, Faculty of Medicine, Ankara Yildirim Beyazit University,Ankara,Turkiye
Abstract
To investigate the e ect of smoking on serum prolidase enzyme activity and proline/hydroxyproline levels. Study Design: A case control study. Place and Duration of the Study: Department of Family Medicine, Ankara Bilkent City Hospital, Family Medicine, Ankara, Turkiye, from June 2022 to May 2023. Methodology: A total of 150 participants were included in the study, including 54 smokers, 43 ex-smokers, and 53 non-smokers. Proline and hydroxyproline concentrations were analysed using a liquid chromatography-mass spectrometre (Sciex QTrap 4500-Foster City-CA). Serum prolidase enzyme activity was determined with the Chinard reagent according to the spectrophotometric test. Multinomial logistic regression analysis compared prolidase activity and amino acid levels among smokers, ex-smokers, and non-smokers. Results: The median values of prolidase enzyme activity were statistically lower in the smoker group 734.2 (643.8-799.6) than in the nonsmoker group 836.8 (755.2-884.2, ² = 0.003, OR = 0.997, 95% CI = 0.994-1,000, p = 0.025. In multiple comparisons, the median values of hydroxyproline were signi cantly higher in the non-smoker group 8.99 (5.76-11.22) than in the ex-smoker 6.05 (4.37-8.21, p = 0.008). Still, no signi cant di erence was found in the multinomial logistic regression analysis (² = -0.051, OR = 0.951, CI 95% = 0.848-1.066, p = 0.384). Conclusion: Serum prolidase enzyme activity was signi cantly lower in smokers than in non-smokers. The prolidase activity may be a fruitful area of study to understand the pathophysiology of smoking-related diseases better.
Publication Details
Page(s) 859-865
Published Journal: Journal of the College of Physicians and Surgeons Pakistan, Volume: 35, Issue: 7, Year: 2025

Request the full text from PASTIC

Keywords
proline, Malignancy, Smoking, COPD, Hydroxyproline, Prolidase, Collagen synthesis
References
Wygrecka M,Alexopoulos I,Potaczek DP,Schaefer L .2022 .Diverse functions of apolipoprotein AI in lung brosisA. m J Physiol Cell Physiol, 10(2) : C438-46.
Yang L,Li Y,Bhattacharya A,Zhang Y .2016 .Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D. Oncotarget, 10(27) : 42340-52.
Yang L,Li Y,Bhattacharya A,Zhang Y. .2052 .PEPD is a pivotal regulator of p53 tumor suppressor. Nat Commun, 10(1) : .
Lubick KJ,Robertson SJ,McNally KL,Freedman BA,Rasmussen AL,Taylor RT .2015 .Flavivirus antagonism of type I interferon signaling reveals prolidase as a regulator of IFNAR1 surface expression. Cell Host Microbe, 06(1) : 61-74.
Kytola V,Topaloglu U,Miller LD,Bitting RL,Goodman MM . .Mutational landscapes of smokingrelated cancers in Caucasians and African Americans: Precision oncology perspectives at Wake Forest Baptist. , : .
Justo BL,Jasiulionis MG .2021 .Characteristics of TIMP1, CD63, and ²1-integrin and the functional impact of their interaction in cancer. Int J Mol Sci, 10(17) : 9319.
Al-Samerria S,Radovick S. Exploring .2023 .the therapeutic potential of targeting GH and IGF-1 in the management of obesity: Insights from the interplay between these hormones and metabolism. Int J Mol Sci, 10(11) : 9556.
Zhong W,Wang X,Wang Y,Sun G,Zhang J,Li Z,Endocrinol Front .2023 .Obesity and endocrine-related cancer: The important role of IGF-1. , 1093257 : 1093257.
Palka JA,Phang JM,Christenson SA,Smith SB,Bafadhel M,Putcha N. .2022 .2): obstructive pulmonary disease. Lancet, 6736(22) : 3-6.
Duygu F,Koruk ST,Karsen H,Aksoy N,Taskin A,Hamidanoglu M. Prolidase .2012 .and oxidative stress in chronic hepatitis C. J Clin Lab Anal, 10(4) : 232-7.
Turkbeyler I,Demir T,Pehlivan Y,Kaplan DS,Ceribasi AO,Orkmez M .2012 .Prolidase could act as a diagnosis and treatment mediator in lung brosisI. n ammation, 10(5) : 1747-52.
Galvin RJ,Ramp WK,Lenz LG .1991 .Comparison of the e ects of smokeless tobacco extract with the e ects of hydroxylase inhibitors on collagenous and noncollagenous protein synthesis by osteoblasts. Connect Tissue Res, 10(3) : 217-29.
Jorgensen LN,Kallehave F,Christensen E,Siana JE,Gottrup F .1998 .Less collagen production in smokers. Surgery, 123(4) : 450-5.
Sienkiewicz P,Palka M,Palka J .2004 .Oxidative stress induces IGFI receptor signaling disturbances in cultured human dermal broblasts. A possible mechanism for collagen biosynthesis inhibition. Cell Mol Biol Lett, 9(4A) : 643-50.
Myara I,Myara A,Mangeot M,Fabre M,Charpentier C .1984 .Lemonnier A. Plasma prolidase activity: A possible index of collagen catabolism in chronic liver disease. Clin Chem, 30(2) : 211-5.
Chinard FP .1952 .Photometric estimation of proline and ornithine. J Biol Chem, 199(1) : 91-5.
Yildirim BB,Kulaksizoglu S. .2024 .Prolidase could be considered a sign of in ammation associated with cigarette smoking. Front Med, 1347688 : 1347688.
Uysal P,Teksoz D,Aksan H,Durmus S,Uslu-Besli L,Cuhadaroglu C .2022 .Relationship between serum sialic acid levels and prolidase activity with air ow obstruction in patients with COPD. Medicine (Baltimore), 10(11) : .
Dehmel S,Nathan P,Bartel S,El-Merhie N,Scherb H,Milger K .2018 .Intrauterine smoke exposure deregulates lung function, pulmonary transcriptomes, and in particular insulin-like growth factor (IGF)-1 in a sex-speci c manner. Sci Rep, 10(1) : 762-5.
Ko JW,Shin NR,Park SH,Lee IC,Ryu JM,Kim HJ,Pt A .2017 .Silibinin inhibits the brotic responses induced by cigarette smoke via suppression of TGF-²1/Smad 2/3 signaling. Food Chem Toxicol, 06 : 424-9.
0

Citations

0

Downloads

39

Views